Menstrual outcomes are frequently overlooked in von Willebrand disease trials

Meaghan O’Donnell, Claire Kelly, Rezan Abdul Kadir, Roseline D’Oiron, Petra Elfvinge, Gaby Golan, Keith Gomez, Samantha C. Gouw, Laura Quintas, Karin P.M. van Galen, Michelle Lavin

Open source

DOI
10.1016/j.rpth.2026.106623
Published
2026-05
Container
Research and Practice in Thrombosis and Haemostasis
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.rpth.2026.106623,
  title = {Menstrual outcomes are frequently overlooked in von Willebrand disease trials},
  author = {Meaghan O’Donnell and Claire Kelly and Rezan Abdul Kadir and Roseline D’Oiron and Petra Elfvinge and Gaby Golan and Keith Gomez and Samantha C. Gouw and Laura Quintas and Karin P.M. van Galen and Michelle Lavin},
  year = {2026},
  journal = {Research and Practice in Thrombosis and Haemostasis},
  doi = {10.1016/j.rpth.2026.106623},
  url = {https://doi.org/10.1016/j.rpth.2026.106623}
}

RIS

TY  - JOUR
TI  - Menstrual outcomes are frequently overlooked in von Willebrand disease trials
AU  - Meaghan O’Donnell
AU  - Claire Kelly
AU  - Rezan Abdul Kadir
AU  - Roseline D’Oiron
AU  - Petra Elfvinge
AU  - Gaby Golan
AU  - Keith Gomez
AU  - Samantha C. Gouw
AU  - Laura Quintas
AU  - Karin P.M. van Galen
AU  - Michelle Lavin
PY  - 2026
JO  - Research and Practice in Thrombosis and Haemostasis
DO  - 10.1016/j.rpth.2026.106623
UR  - https://doi.org/10.1016/j.rpth.2026.106623
ER  - 

APA

O’Donnell, M., Kelly, C., Kadir, R. A., D’Oiron, R., Elfvinge, P., Golan, G., Gomez, K., Gouw, S. C., Quintas, L., Galen, K. P. V., & Lavin, M. (2026). Menstrual outcomes are frequently overlooked in von Willebrand disease trials. Research and Practice in Thrombosis and Haemostasis. https://doi.org/10.1016/j.rpth.2026.106623

Source records